Patents by Inventor Jin Huh

Jin Huh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210114998
    Abstract: Provided is a compound of Chemical Formula 1: wherein X is O or S; L1 and L2 each independently is a direct bond or a substituted or unsubstituted arylene group; X1 is N or CR1, X2 is N or CR2, X3 is N or CR3, and at least two of X1 to X3 are N; R1 to R3 each independently is hydrogen, deuterium, or a substituted or unsubstituted alkyl, aryl or heteroaryl group; Ar1 and Ar2 each independently is hydrogen, deuterium, or a substituted or unsubstituted alkyl, aryl or heteroaryl group; positions at which is substituted with are asymmetric; m1, m2, n1 and n2 each independently is 0 or 1; and m1+m2 is 1, and n1+n2 is 1, and an organic light emitting device comprising the same.
    Type: Application
    Filed: March 8, 2019
    Publication date: April 22, 2021
    Inventors: Dong Uk HEO, Jin Joo KIM, Dong Hoon LEE, Jungoh HUH, Yongbum CHA, Wanpyo HONG
  • Publication number: 20210118649
    Abstract: A matching network for a system having a non-linear load and powered by a first RF power supply operating at a first frequency and a second RF power supply operating at a second frequency. The matching network includes a first matching network section for providing an impedance match between the first power supply and the load. The matching network also includes a second matching network section for providing an impedance match between the second power supply and the load. A the first matching network section includes a first variable reactance, and the variable reactance is controlled in accordance with IMD sensed in the signal applied to the load by the first RF power supply. The variable reactance is adjusted in accordance with the IMD to reduce the detected IMD.
    Type: Application
    Filed: October 19, 2020
    Publication date: April 22, 2021
    Inventors: Jin HUH, Aaron T. RADOMSKI, Duy NGUYEN, Soohan KIM
  • Patent number: 10960056
    Abstract: A peptide with anti-inflammatory activity, wherein the peptide comprises SEQ ID NO: 1, the peptide has above 80% homology of amino acid with above-mentioned sequence, or the peptide is the fragment of the above-mentioned peptides is described. An anti-inflammatory composition comprising the above mentioned peptides is described. According to the present invention, a peptide comprising a sequence of SEQ ID NO: 1 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptide of this invention can be used as anti-inflammatory pharmaceutical composition or as cosmetic composition, in turn, treating and preventing a variety of different types of inflammatory diseases.
    Type: Grant
    Filed: July 2, 2018
    Date of Patent: March 30, 2021
    Assignee: GemVax & KAEL Co., Ltd.
    Inventors: Sang Jae Kim, Kyung Hee Kim, Kyu-Yong Lee, Seong-Ho Koh, Hyun-Hee Park, Sung Jin Huh, Woo Jin Lee, Bum Joon Kim
  • Publication number: 20210091528
    Abstract: A laser irradiating device preferably includes: a reflector having a receiving space formed therein; a flash lamp inserted and mounted in the reflector to generate light; a laser rod for resonating light incident from the flash lamp to emit a laser; a capacitor for storing, for a predetermined time interval, voltage to be supplied to the flash lamp; a digital variable resistor unit for outputting different voltages according to configured resistance values; a voltage increasing unit for increasing voltage input from the digital variable resistor unit and supplying the increased voltage to the capacitor; a control unit which stores resistance values corresponding to laser irradiating levels and configures a resistance value corresponding to the configured laser irradiating level; and a trigger circuit unit turned on according to a control of the user to supply a charge voltage of the capacitor to the flash lamp.
    Type: Application
    Filed: May 14, 2019
    Publication date: March 25, 2021
    Inventor: Jin HUH
  • Publication number: 20210085757
    Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises at least one amino acid sequence among SEQ ID NO: 2 to SEQ ID NO: 179, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, the peptides that have at least one amino acid sequence of SEQ ID NO: 2 to SEQ ID NO: 179 shows outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptides of this invention can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.
    Type: Application
    Filed: December 4, 2020
    Publication date: March 25, 2021
    Inventors: Sang Jae KIM, Kyung Hee KIM, Kyu-Yong LEE, Seong-Ho KOH, Hyun-Hee PARK, Sung Jin HUH, Woo Jin LEE, Bum Joon KIM
  • Patent number: 10888606
    Abstract: A peptide with anti-inflammatory activity is described, wherein the peptide comprises at least one amino acid sequence among SEQ ID NO: 2 to SEQ ID NO: 179, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The peptides that have at least one amino acid sequence of SEQ ID NO: 2 to SEQ ID NO: 179 shows outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising those peptides can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: January 12, 2021
    Assignee: GEMVAX & KAEL CO., LTD.
    Inventors: Sang Jae Kim, Kyung Hee Kim, Kyu-Yong Lee, Seong-Ho Koh, Hyun-Hee Park, Sung Jin Huh, Woo Jin Lee, Bum Joon Kim
  • Publication number: 20200325472
    Abstract: Disclosed herein is a subgenomic promoter library derived from alphavirus. Also provided herein are methods of using the subgenomic promoters to produce antibodies and other molecules.
    Type: Application
    Filed: February 7, 2020
    Publication date: October 15, 2020
    Applicant: Massachusetts Institute of Technology
    Inventors: Ron Weiss, Jin Huh
  • Publication number: 20200291428
    Abstract: Provided herein are engineered HSV-1 vectors comprising a modified HSV-1 genome. The engineered HSV-1 vectors can be used to deliver genetic circuits (e.g., up to 100 kb) to cells in vitro or in vivo. Methods of treating or diagnosing a disease (e.g., cancer) using the engineered HSV-1 vectors described herein are also provided.
    Type: Application
    Filed: January 14, 2020
    Publication date: September 17, 2020
    Applicant: Massachusetts Institute of Technology
    Inventors: Ron Weiss, Maria Hottelet Foley, Jin Huh, Ross D. Jones
  • Publication number: 20200283796
    Abstract: Provided herein, in some aspects, are antibody expression systems comprising DNA launched RNA replicons for high level antibody expression. In some embodiments, the antibody is a therapeutic antibody. In some embodiments, the antibody is an immune check point inhibitor. Methods of using the antibody expression system for treating diseases (e.g., cancer) are also provided.
    Type: Application
    Filed: March 5, 2020
    Publication date: September 10, 2020
    Applicant: Massachusetts Institute of Technology
    Inventors: Ron Weiss, Jin Huh, Jacob Becraft
  • Publication number: 20200208127
    Abstract: The present invention relates to methods of treating or preventing inflammation with a peptide having anti-inflammatory activity, wherein the peptide consists of the amino acid sequence of SEQ ID NO: 101. According to the present invention, the peptide of SEQ ID NO: 101 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the method comprising administration of the peptide of this invention can be used in anti-inflammatory pharmaceutical or cosmetic applications, in turn, treating and preventing a variety of different types of inflammatory diseases.
    Type: Application
    Filed: March 13, 2020
    Publication date: July 2, 2020
    Applicant: GemVax & KAEL Co., Ltd.
    Inventors: Sang Jae KIM, Kyung Hee Kim, Kyu-Yong Lee, Seong-Ho KOH, Bum Joon Kim, Hyun-Hee PARK, Sung Jin HUH, Woo Jin LEE, Hwain JANG, Jung Soon HA
  • Publication number: 20200140832
    Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises any one amino acid sequence of SEQ ID NO:1 to SEQ ID NO:161, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, a peptide that has at least one amino acid sequence of SEQ ID NO:1 to SEQ ID NO:161 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptides of this invention can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.
    Type: Application
    Filed: January 17, 2020
    Publication date: May 7, 2020
    Inventors: Sang Jae KIM, Kyung Hee KIM, Kyu-Yong LEE, Seong-Ho KOH, Bum Joon KIM, Hyun-Hee PARK, Sung Jin HUH, Woo Jin LEE, Hwain JANG, Jung Soon HA
  • Publication number: 20200056189
    Abstract: Provided herein are genetic circuits and cell state classifiers for detecting the microRNA profile of a cell. The cell state classifiers of the present disclosure utilize phosphorylation state of a transcription factor to control classifier output. Kinases and phosphatase pairs that function in phosphorylating or dephosphorylating the transcription factor are integrated into the circuit, their expression tuned by the presence of microRNAs of interest (e.g., in a cell). The genetic circuits and cell state classifiers may be used in various applications (e.g., therapeutic or diagnostic applications).
    Type: Application
    Filed: August 1, 2019
    Publication date: February 20, 2020
    Applicant: Massachusetts Institute of Technology
    Inventors: Ron Weiss, Ross D. Jones, Jin Huh
  • Publication number: 20200040338
    Abstract: Provided herein are genetic circuits and cell state classifiers for detecting the microRNA profile of a cell. In some embodiments, the cell state classifiers described herein utilize an endoribonuclease and a self-amplifying RNA molecule for controlling the expression of an output molecule. In some embodiments, the cell state classifiers described herein are encoded on a single RNA transcript, which is then processed to produce individual genetic circuits that function independently. The genetic circuits and cell state classifiers described herein may be used in various applications (e.g., therapeutic or diagnostic applications).
    Type: Application
    Filed: August 1, 2019
    Publication date: February 6, 2020
    Applicant: Massachusetts Institute of Technology
    Inventors: Ron Weiss, Kevin J. Lebo, Jin Huh
  • Patent number: 10536130
    Abstract: A single input multiple output plasma control system includes a splitter that receives a single input and generates multiple outputs. Each output from the splitter is provided to a load. The splitter includes branch circuits connected between selected splitter outputs. The branch circuits control voltage, current, power, frequency, or phase between each branch to enable controlling a predetermined relationship between the voltage, current, power, impedance, frequency, or phase measured at each load.
    Type: Grant
    Filed: August 24, 2018
    Date of Patent: January 14, 2020
    Assignee: MKS Instruments, inc.
    Inventors: David J. Coumou, Dennis M. Brown, Jeongseok Jang, Jin Huh
  • Patent number: 10408424
    Abstract: A housing or pocket for supporting a light guide device for an illumination device, especially for a motor vehicle or an indicator device in a rearview device of a motor vehicle. The housing has a first side which is configured to support the light guiding device for exposure to the pictogram of the reflection layer. The housing also include a second side containing exposed wire connectors to connect the light guide device to a power source. One of the light guide device, the printed circuit board or both structures are fitted with an encapsulation member and secured to the housing through the use of a fixative mount.
    Type: Grant
    Filed: August 31, 2018
    Date of Patent: September 10, 2019
    Assignee: SMR Patents S.à.r.l.
    Inventors: Norbert Kürschner, Andreas Herrmann, Chun Seop Kwak, Ho Jin Huh
  • Patent number: 10374911
    Abstract: The present disclosure is related to device management in a machine to machine (M2M) network. Particularly, the present disclosure relates to performing an efficient device management based on correlations between M2M devices in the M2M network.
    Type: Grant
    Filed: February 26, 2014
    Date of Patent: August 6, 2019
    Assignee: KT CORPORATION
    Inventors: Hwi-Jung Ryu, Mi-Kyoung Kang, Yong Kwon, Sung-Ihk Yang, Kwang-Jin Lee, Sung-Kooc Lim, Yu-Jin Huh
  • Publication number: 20190192638
    Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises at least one amino acid sequence among SEQ ID NO: 2 to SEQ ID NO: 179, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, the peptides that have at least one amino acid sequence of SEQ ID NO: 2 to SEQ ID NO: 179 shows outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptides of this invention can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.
    Type: Application
    Filed: December 21, 2018
    Publication date: June 27, 2019
    Inventors: Sang Jae Kim, Kyung Hee Kim, Kyu-Yong Lee, Seong-Ho Koh, Hyun-Hee Park, Sung Jin Huh, Woo Jin Lee, Bum Joon Kim
  • Publication number: 20190068158
    Abstract: A single input multiple output plasma control system includes a splitter that receives a single input and generates multiple outputs. Each output from the splitter is provided to a load. The splitter includes branch circuits connected between selected splitter outputs. The branch circuits control voltage, current, power, frequency, or phase between each branch to enable controlling a predetermined relationship between the voltage, current, power, impedance, frequency, or phase measured at each load.
    Type: Application
    Filed: August 24, 2018
    Publication date: February 28, 2019
    Inventors: David J. COUMOU, Dennis M. BROWN, Jeongseok JANG, Jin HUH
  • Patent number: 10206981
    Abstract: A peptide with anti-inflammatory activity is described, wherein the peptide comprises at least one amino acid sequence among SEQ ID NO: 2 to SEQ ID NO: 179, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The peptides that have at least one amino acid sequence of SEQ ID NO: 2 to SEQ ID NO: 179 shows outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising those peptides can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.
    Type: Grant
    Filed: November 17, 2016
    Date of Patent: February 19, 2019
    Assignee: GemVax & KAEL Co., Ltd.
    Inventors: Sang Jae Kim, Kyung Hee Kim, Kyu-Yong Lee, Seong-Ho Koh, Hyun-Hee Park, Sung Jin Huh, Woo Jin Lee, Bum Joon Kim
  • Publication number: 20190030137
    Abstract: A peptide with anti-inflammatory activity, wherein the peptide comprises SEQ ID NO: 1, the peptide has above 80% homology of amino acid with above-mentioned sequence, or the peptide is the fragment of the above-mentioned peptides is described. An anti-inflammatory composition comprising the above mentioned peptides is described. According to the present invention, a peptide comprising a sequence of SEQ ID NO: 1 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptide of this invention can be used as anti-inflammatory pharmaceutical composition or as cosmetic composition, in turn, treating and preventing a variety of different types of inflammatory diseases.
    Type: Application
    Filed: July 2, 2018
    Publication date: January 31, 2019
    Applicant: GemVax & KAEL Co., Ltd.
    Inventors: Sang Jae Kim, Kyung Hee Kim, Kyu-Yong Lee, Seong-Ho Koh, Hyun-Hee Park, Sung Jin Huh, Woo Jin Lee, Bum Joon Kim